These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36592228)

  • 1. Ca
    El Ghaleb Y; Flucher BE
    Handb Exp Pharmacol; 2023; 279():263-288. PubMed ID: 36592228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CACNA1I gain-of-function mutations differentially affect channel gating and cause neurodevelopmental disorders.
    El Ghaleb Y; Schneeberger PE; Fernández-Quintero ML; Geisler SM; Pelizzari S; Polstra AM; van Hagen JM; Denecke J; Campiglio M; Liedl KR; Stevens CA; Person RE; Rentas S; Marsh ED; Conlin LK; Tuluc P; Kutsche K; Flucher BE
    Brain; 2021 Aug; 144(7):2092-2106. PubMed ID: 33704440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysing an allelic series of rare missense variants of CACNA1I in a Swedish schizophrenia cohort.
    Baez-Nieto D; Allen A; Akers-Campbell S; Yang L; Budnik N; Pupo A; Shin YC; Genovese G; Liao M; Pérez-Palma E; Heyne H; Lal D; Lipscombe D; Pan JQ
    Brain; 2022 Jun; 145(5):1839-1853. PubMed ID: 34919654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal Cav3 channelopathies: recent progress and perspectives.
    Lory P; Nicole S; Monteil A
    Pflugers Arch; 2020 Jul; 472(7):831-844. PubMed ID: 32638069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the gating brake in the I-II loop of CaV3 T-type calcium channels.
    Perez-Reyes E
    Channels (Austin); 2010; 4(6):453-8. PubMed ID: 21099341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare schizophrenia risk variant of CACNA1I disrupts Ca
    Andrade A; Hope J; Allen A; Yorgan V; Lipscombe D; Pan JQ
    Sci Rep; 2016 Oct; 6():34233. PubMed ID: 27756899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional impact of alternative splicing of human T-type Cav3.3 calcium channels.
    Murbartián J; Arias JM; Perez-Reyes E
    J Neurophysiol; 2004 Dec; 92(6):3399-407. PubMed ID: 15254077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Cav3.2 T-type Calcium Channels by Its Intracellular I-II Loop.
    Monteil A; Chausson P; Boutourlinsky K; Mezghrani A; Huc-Brandt S; Blesneac I; Bidaud I; Lemmers C; Leresche N; Lambert RC; Lory P
    J Biol Chem; 2015 Jun; 290(26):16168-76. PubMed ID: 25931121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of T-type calcium channels.
    Perez-Reyes E
    Cell Calcium; 2006 Aug; 40(2):89-96. PubMed ID: 16759699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA
    Cain SM; Garcia E; Waheed Z; Jones KL; Bushell TJ; Snutch TP
    Channels (Austin); 2017 Nov; 11(6):574-586. PubMed ID: 28742985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of T-type calcium channels.
    Perez-Reyes E; Lory P
    CNS Neurol Disord Drug Targets; 2006 Dec; 5(6):605-9. PubMed ID: 17168745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Channelopathies of voltage-gated L-type Cav1.3/α
    Torrente AG; Mesirca P; Bidaud I; Mangoni ME
    Pflugers Arch; 2020 Jul; 472(7):817-830. PubMed ID: 32601767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compensatory reduction of Cav3.1 expression in thalamocortical neurons of juvenile rats of WAG/Rij model of absence epilepsy.
    Sharop BR; Boldyriev OI; Batiuk MY; Shtefan NL; Shuba YM
    Epilepsy Res; 2016 Jan; 119():10-2. PubMed ID: 26656778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heantos-4, a natural plant extract used in the treatment of drug addiction, modulates T-type calcium channels and thalamocortical burst-firing.
    Cain SM; Ahn S; Garcia E; Zhang Y; Waheed Z; Tyson JR; Yang Y; Van Sung T; Phillips AG; Snutch TP
    Mol Brain; 2016 Dec; 9(1):94. PubMed ID: 27919294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CACNA1H missense mutations associated with amyotrophic lateral sclerosis alter Cav3.2 T-type calcium channel activity and reticular thalamic neuron firing.
    Rzhepetskyy Y; Lazniewska J; Blesneac I; Pamphlett R; Weiss N
    Channels (Austin); 2016 Nov; 10(6):466-77. PubMed ID: 27331657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex modulation of Ca(v)3.1 T-type calcium channel by nickel.
    Nosal OV; Lyubanova OP; Naidenov VG; Shuba YM
    Cell Mol Life Sci; 2013 May; 70(9):1653-61. PubMed ID: 23250353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of S4 segments and S4-S5 linkers to the low-voltage activation properties of T-type CaV3.3 channels.
    Sanchez-Sandoval AL; Herrera Carrillo Z; Díaz Velásquez CE; Delgadillo DM; Rivera HM; Gomora JC
    PLoS One; 2018; 13(2):e0193490. PubMed ID: 29474447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of neuronal Ca
    Cmarko L; Weiss N
    Mol Brain; 2020 Jun; 13(1):95. PubMed ID: 32560664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms by which a CACNA1H mutation in epilepsy patients increases seizure susceptibility.
    Eckle VS; Shcheglovitov A; Vitko I; Dey D; Yap CC; Winckler B; Perez-Reyes E
    J Physiol; 2014 Feb; 592(4):795-809. PubMed ID: 24277868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene.
    Chemin J; Siquier-Pernet K; Nicouleau M; Barcia G; Ahmad A; Medina-Cano D; Hanein S; Altin N; Hubert L; Bole-Feysot C; Fourage C; Nitschké P; Thevenon J; Rio M; Blanc P; Vidal C; Bahi-Buisson N; Desguerre I; Munnich A; Lyonnet S; Boddaert N; Fassi E; Shinawi M; Zimmerman H; Amiel J; Faivre L; Colleaux L; Lory P; Cantagrel V
    Brain; 2018 Jul; 141(7):1998-2013. PubMed ID: 29878067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.